UiPath delivered a clean quarter on September 3 and the market punished it anyway. Revenue of $410.26 million exceeded the $397.77 million Wall Street forecast by $12.49 million, or about 3%. Annual recurring revenue rose 12% from a year earlier to $1.938 billion, and the company posted its fourth straight quarter of GAAP profitability. That is a company executing. But execution without acceleration is not enough for a growth software stock priced for something more.
The stock experienced a 16.63% decline the next trading day, September 4, after the announcement. Analysts are cautious due to increased competition in AI-driven automation, impacting investor sentiment. The pattern is familiar: UiPath has spent two years proving it can grow steadily, while the market has waited for evidence it can grow fast.
Why This Stock Now
The next meaningful test arrives on September 22. UiPath will host an Investor Day in Las Vegas starting at 11:30 am PT. Analysts have described the event as a critical catalyst, with some expecting management to provide preliminary fiscal 2028 guidance, including an annual recurring revenue growth target above 10%, a threshold some believe may require additional acquisitions to achieve organically.
The honest tension in UiPath’s story is timing. The company has been investing heavily in its transition toward what it calls agentic automation, software that coordinates AI agents, traditional robotic process automation, and human workers in unified workflows. That is directionally right. The question is whether it shows up in ARR before competitors close the gap.
The Business
UiPath orchestrates automation across enterprise workflows, combining robotic process automation with AI agents managed through its Maestro platform. Maestro Flow, the latest product, works with coding agents such as Claude Code, Cursor, and GitHub Copilot from developer environments, coordinating AI agents, robots, APIs, documents, and people while providing enterprise-grade execution and governance. Early adopters have reported meaningful efficiency gains, and management highlighted its partner ecosystem in the quarter, including firms like Deloitte and Accenture.
Net new ARR of $37 million was up significantly year over year on an organic, constant currency basis. That figure is accelerating. The trailing ARR growth rate of 12% understates where the business is heading if agentic upsells begin landing at scale.
What Could Go Wrong
Competition from Microsoft and others presents real risk; dollar-based net retention at 109% needs to improve for higher growth to materialize. Microsoft is packaging automation directly into its enterprise suite, which pressures UiPath on price and on procurement conversations. Winning the agentic cycle requires UiPath to be the preferred orchestration layer even when Microsoft is already at the table.
The Bottom Line
UiPath’s post-earnings drop has opened a gap between what the company is delivering and what the stock reflects. At around $15.20, the stock traded at a P/E ratio in the low 20s. Full-year revenue guidance points to $1.789 billion to $1.794 billion, with non-GAAP operating income of about $445 million. September 22 is the event that changes the conversation from quarterly noise to long-term conviction. If management delivers a credible 2028 roadmap with accelerating ARR, the current price will look like a gift.
